We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kings Arms Yard Vct Plc | LSE:KAY | London | Ordinary Share | GB0007174294 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.40 | 18.90 | 19.90 | 19.40 | 19.40 | 19.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 3.32M | 726k | 0.0014 | 138.57 | 100.91M |
TIDMKAY
Kings Arms Yard VCT PLC
Interim Management Statement
LEI Code 213800DK8H27QY3J5R45
Introduction
I present Kings Arms Yard VCT PLC's (the "Company") interim management statement for the period from 1 July 2021 to 30 September 2021.
Performance and dividends
The Company's unaudited net asset value (NAV) as at 30 September 2021 was GBP106.5 million or 24.30 pence per share (excluding treasury shares), an increase of 0.31 pence per share (1.3 per cent.) since 30 June 2021.
After accounting for the second interim dividend for the year ending 31 December 2021 of 0.60 pence per share and the special dividend of 1.14 pence per share paid on 29 October 2021 to shareholders on the register on 1 October 2021, the NAV is 22.56 pence per share.
Portfolio
The following investments have been made during the period from 1 July 2021 to 30 September 2021:
Further investments GBP'000 Activity ------------ ------- ---------------------------------------------------------- Technology enabled service business in medical nutritional Oviva AG 829 therapy (MNT). ------------ ------- ---------------------------------------------------------- The Evewell Group Operator and developer of women's health centres focusing Limited 386 on fertility. ------------ ------- ---------------------------------------------------------- Provider of automated software testing and an enhanced Imandra Inc. 47 learning experience for artificial neural networks. ------------ ------- ---------------------------------------------------------- Total further investments 1,262 ------------ -------
The following disposals were made during the period from 1 July 2021 to 30 September 2021:
Cost Proceeds Portfolio Company GBP'000 GBP'000 ----------------------- -------- -------- Antenova Limited 1,733 5,239 ----------------------- -------- -------- Elateral Group Limited 5,488 410 ----------------------- -------- -------- Total 7,221 5,649 ----------------------- -------- --------
Top ten holdings as at 30 September 2021:
Portfolio Carrying value % of Activity company GBP'000 net asset value ------------ -------------- ----- ----------------------------------------------------------- Proveca 9,569 9.0 UK based pharma company specialising in medicines Limited for children. ------------ -------------- ----- ----------------------------------------------------------- Quantexa 9,126 8.6 Network analytics platform to detect financial crime. Limited ------------ -------------- ----- ----------------------------------------------------------- Egress 5,845 5.5 Encrypted email and file transfer service provider. Software Technologies Limited ------------ -------------- ----- ----------------------------------------------------------- Chonais 3,199 3.0 Owner and operator of a 2 MW hydro-power scheme in River Hydro the Scottish Highlands. Limited ------------ -------------- ----- ----------------------------------------------------------- Oviva AG 2,982 2.8 Technology enabled service business in medical nutritional therapy (MNT). ------------ -------------- ----- ----------------------------------------------------------- MyMeds&Me 1,899 1.8 Provides a platform for collecting data from pharmaceutical Limited adverse events. ------------ -------------- ----- ----------------------------------------------------------- The Street 1,838 1.7 Owner and operator of photovoltaic systems on domestic by Street properties in the UK. Solar Programme Limited ------------ -------------- ----- ----------------------------------------------------------- Sift Limited 1,698 1.6 Web based provision of online business and community management solutions. ------------ -------------- ----- ----------------------------------------------------------- Phrasee 1,689 1.6 AI platform that generates optimised marketing campaigns. Limited ------------ -------------- ----- ----------------------------------------------------------- The Evewell 1,666 1.6 Operator and developer of women's health centres focusing Group on fertility. Limited ------------ -------------- ----- -----------------------------------------------------------
Share buy-backs
During the period from 1 July 2021 to 30 September 2021, the Company purchased 1,682,551 shares for GBP357,000 (including stamp duty) at an average price of 21.14 pence per share. All of the shares are to be held in treasury.
It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.
It is the Board's intention for such buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.
Fundraising
The Company announced on 18 October 2021 that, subject to obtaining the requisite regulatory approval, it intended to launch a prospectus top up offer of new ordinary shares. Full details of the Offer will be contained in a prospectus that is expected to be published in early January 2022.
Material events and transactions after the period end
The Company had no material investment transactions following the period end.
Other than as described above, there have been no material events or transactions during the quarter and to the date of this announcement.
Further information
The Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this scheme can be found at www.albion.capital/funds/KAY.
Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's webpage on the Manager's website under www.albion.capital/funds/KAY.
Fiona Wollocombe, Chairman
25 November 2021
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP -- Tel: 020 7601 1850
(END) Dow Jones Newswires
November 25, 2021 09:23 ET (14:23 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Kings Arms Yard Vct Chart |
1 Month Kings Arms Yard Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions